Enlarged adrenal gland in fetus of maternal diabetes

Completed

• Conditions: fetal adrenal gland size in gestational and pre-gestational diabetic mellitus pregnancy; fetal adrenal gland; gestational diabetes mellitus; pre-gestational diabetic mellitus

• Registration Number: TCTR20211113003
• Lead Sponsor: Bhumibol Adulyadej Hospital Royal Thai Air Force

Brief Summary

The prevalence of enlarged fetal adrenal gland was 36.5 percent. Which was not significantly different among 3 types of DM. Two-thirds of GDMA2 and PGDM had poorly controlled glycemic level, and PGDM group had larger fetal adrenal than GDMA2 group. All enlarged adrenal gland fetuses significantly had neonatal hypoglycemia (p 0.016). Mean birth weight, incidence of neonatal intensive care unit (NICU) admission, respiratory complications, and polycythemia among these 3 groups were comparable.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-11-13
• Study Completion: 2021-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 126

Inclusion Criteria

diabetes pregnant women with gestational ages (GA) range between 28 to 36+6 weeks

Exclusion Criteria

fetal abnormality of genetic or kidney or adrenal gland
incomplete information

Study & Design

• Study Type: Observational
• Study Design: Not specified